Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor) September 1, 2021
Insilico Medicine taps 4B Technologies’ neurological know-how to build AI-designed ALS drugs August 27, 2021
NYCM Insurance Launches Snapsheet Payments Software to Enable Digital Payment Options for Claimants and Vendors August 26, 2021
Ultragenyx Announces Approval of Dojolvi® (triheptanoin) in Brazil for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Adults and Children August 23, 2021
Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab) August 19, 2021